Acute Responses to Diuretic Therapy in Extremely Low Gestational Age Newborns: Results from the Prematurity and Respiratory Outcomes Program Cohort Study
- PMID: 29599068
- PMCID: PMC5970973
- DOI: 10.1016/j.jpeds.2018.01.066
Acute Responses to Diuretic Therapy in Extremely Low Gestational Age Newborns: Results from the Prematurity and Respiratory Outcomes Program Cohort Study
Abstract
Objective: To determine if daily respiratory status improved more in extremely low gestational age (GA) premature infants after diuretic exposure compared with those not exposed in modern neonatal intensive care units.
Study design: The Prematurity and Respiratory Outcomes Program (PROP) was a multicenter observational cohort study of 835 extremely premature infants, GAs of 230/7-286/7 weeks, enrolled in the first week of life from 13 US tertiary neonatal intensive care units. We analyzed the PROP study daily medication and respiratory support records of infants ≤34 weeks postmenstrual age. We determined whether there was a temporal association between the administration of diuretics and an acute change in respiratory status in premature infants in the neonatal intensive care unit, using an ordered categorical ranking of respiratory status.
Results: Infants in the diuretic exposed group of PROP were of lower mean GA and lower mean birth weight (P < .0001). Compared with infants unexposed to diuretics, the probability (adjusted for infant characteristics including GA, birth weight, sex, and respiratory status before receiving diuretics) that the exposed infants were on a higher level of respiratory support was significantly greater (OR, >1) for each day after the initial day of diuretic exposure.
Conclusions: Our analysis did not support the ability of diuretics to substantially improve the extremely premature infant's respiratory status. Further study of both safety and efficacy of diuretics in this setting are warranted.
Trial registration: Clinicaltrials.gov: NCT01435187.
Keywords: diuretic; prematurity; respiratory distress.
Published by Elsevier Inc.
Figures

Comment in
-
Reply.J Pediatr. 2018 Oct;201:298. doi: 10.1016/j.jpeds.2018.06.042. Epub 2018 Jul 13. J Pediatr. 2018. PMID: 30017340 No abstract available.
-
Diuretics in newborns born extremely premature: the jury is still out.J Pediatr. 2018 Oct;201:298. doi: 10.1016/j.jpeds.2018.06.040. Epub 2018 Jul 17. J Pediatr. 2018. PMID: 30029857 No abstract available.
Similar articles
-
Characteristics of Extremely Low Gestational Age Newborns Undergoing Tracheotomy: A Secondary Analysis of the Trial of Late Surfactant Randomized Clinical Trial.JAMA Otolaryngol Head Neck Surg. 2017 Jan 1;143(1):13-19. doi: 10.1001/jamaoto.2016.2428. JAMA Otolaryngol Head Neck Surg. 2017. PMID: 27583380 Clinical Trial.
-
Diuretic exposure in premature infants from 1997 to 2011.Am J Perinatol. 2015 Jan;32(1):49-56. doi: 10.1055/s-0034-1373845. Epub 2014 May 6. Am J Perinatol. 2015. PMID: 24801161 Free PMC article.
-
Hypertension induced by pregnancy and neonatal outcome: Results from a retrospective cohort study in preterm under 34 weeks.PLoS One. 2021 Aug 18;16(8):e0255783. doi: 10.1371/journal.pone.0255783. eCollection 2021. PLoS One. 2021. PMID: 34407091 Free PMC article.
-
Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.Neonatology. 2015;107(4):358-9. doi: 10.1159/000381132. Epub 2015 Jun 5. Neonatology. 2015. PMID: 26044104 Review.
-
Outcomes for extremely premature infants.Anesth Analg. 2015 Jun;120(6):1337-51. doi: 10.1213/ANE.0000000000000705. Anesth Analg. 2015. PMID: 25988638 Free PMC article. Review.
Cited by
-
An Update on the Prevention and Management of Bronchopulmonary Dysplasia.Pediatric Health Med Ther. 2021 Aug 11;12:405-419. doi: 10.2147/PHMT.S287693. eCollection 2021. Pediatric Health Med Ther. 2021. PMID: 34408533 Free PMC article. Review.
-
Furosemide use in Italian neonatal intensive care units: a national survey.Ital J Pediatr. 2020 Jun 22;46(1):86. doi: 10.1186/s13052-020-00851-2. Ital J Pediatr. 2020. PMID: 32571386 Free PMC article.
-
Bronchopulmonary Dysplasia: Then, Now, and Next.Pediatr Allergy Immunol Pulmonol. 2020 Sep;33(3):99-109. doi: 10.1089/ped.2020.1205. Pediatr Allergy Immunol Pulmonol. 2020. PMID: 35922031 Free PMC article. Review.
-
World Prematurity Day: it takes an NIH village to prevent preterm birth and improve treatments for preterm infants.Am J Physiol Lung Cell Mol Physiol. 2021 Nov 1;321(5):L960-L969. doi: 10.1152/ajplung.00401.2021. Epub 2021 Oct 13. Am J Physiol Lung Cell Mol Physiol. 2021. PMID: 34643102 Free PMC article.
-
Weaning and extubation from neonatal mechanical ventilation: an evidenced-based review.BMC Pulm Med. 2022 Nov 16;22(1):421. doi: 10.1186/s12890-022-02223-4. BMC Pulm Med. 2022. PMID: 36384517 Free PMC article. Review.
References
-
- Isayama T, Lee SK, Yang J, Lee D, Daspal S, Dunn M, et al. Revisiting the Definition of Bronchopulmonary Dysplasia: Effect of Changing Panoply of Respiratory Support for Preterm Neonates. JAMA Pediatr. 2017;171:271–279. - PubMed
-
- Engelhardt B, Elliott S, Hazinski TA. Short- and long-term effects of furosemide on lung function in infants with bronchopulmonary dysplasia. J Pediatr. 1986;109:1034–1039. - PubMed
-
- Flemmer A, Simbruner G, Muenzer S, Proquitte H, Haberi C, Nicolai T, et al. Effect of lung water content, manipulated by intratracheal furosemide, surfactant, or a mixture of both, on compliance and viscoelastic tissue forces in lung-lavaged newborn piglets. Crit Care Med. 2000;28:1911–1917. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical